<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02136264</url>
  </required_header>
  <id_info>
    <org_study_id>PCFADASH-HT</org_study_id>
    <nct_id>NCT02136264</nct_id>
  </id_info>
  <brief_title>Study of Personalized Dietary Intervention for the Control of Essential Hypertension</brief_title>
  <acronym>PCFADASH-HT</acronym>
  <official_title>Randomized Controlled Trial of a Personalized Dietary Intervention Approach for the Control of Essential Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nigeria, Enugu Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Glasgow</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Of Nigeria Teaching Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Nigeria, Enugu Campus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An ongoing case study of psoriasis, shows reproducibly that ingestion of hydrogenated fats,
      and some flavourant or sweetener compounds, leads to relapse of psoriasis, and secondary food
      intolerances, followed by remission over a couple of months (cpcpsoriasis.blogspot.com).
      Hence a personalized categorical food avoidance diet averts relapse and maintains remission
      of psoriasis, with side benefit on blood pressure and other metabolic parameters (J
      Hypertension 2012; 30: e-suppl 1, poster 158). Study hypothesis: this dietary approach would
      improve the control of essential hypertension. A randomized controlled clinical trial is
      proposed to compare this dietary approach with conventional DASH-type dietary counselling. 40
      study participants will be randomly assigned to either conventional or interventional dietary
      counselling. They will be comprehensively monitored (including gene expression studies) for
      two years. Outcome criteria will include blood pressure, complications of hypertension,
      side-benefit on comorbidity, and requirement for antihypertensive drugs.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>a statistically significant 12 mm Hg (or more) greater change of blood pressure in one group compared to the other</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>resolution of hypertension (normal blood pressure, no drugs required)</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serious (disabling) adverse events attributable to hypertension or its drug treatment</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>a reduction in antihypertensive treatment required i.e. reduced number of drugs required, or dosage of at least two drugs reduced by half</measure>
    <time_frame>2 years</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Essential Hypertension</condition>
  <arm_group>
    <arm_group_label>PCFA interventional dietary counselling</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>personalized categorical food avoidance dietary counselling</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional DASH diet counselling</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>DASH = conventional &quot;dietary approach to stop hypertension&quot;</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PCFA interventional dietary counselling</intervention_name>
    <arm_group_label>PCFA interventional dietary counselling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>conventional DASH diet counselling</intervention_name>
    <arm_group_label>conventional DASH diet counselling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. average blood pressure exceeds 160/100mm Hg (140/90 if additional vascular risk),
             regardless of whether on treatment

          2. on one or two antihypertensive drugs AND average BP exceeds 140/90 (130/80 if
             additional risk)

          3. on three or more antihypertensives, regardless of whether BP controlled

          4. sufficiently literate to follow detailed dietary instructions

          5. informed consent

        Exclusion Criteria:

          1. disabling complications of hypertension

          2. secondary cause of hypertension

          3. pregnancy

          4. age less than 18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chioli P Chijioke, MA MB BChir MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>College of Medicine, University of Nigeria</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nnamdi Nwosu, MB BS FWACP</last_name>
    <phone>+2348037123803</phone>
    <email>dykenig@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chiolive International Medical Research Organisation</name>
      <address>
        <city>Enugu</city>
        <zip>400001</zip>
        <country>Nigeria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bridget Nwokolo, BSc Nursing Science</last_name>
      <phone>+2348060281994</phone>
      <email>bridgetnwokolocd2007@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Nnamdi Nwosu, MB BS FWACP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Nigeria</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 8, 2014</study_first_submitted>
  <study_first_submitted_qc>May 8, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2014</study_first_posted>
  <last_update_submitted>November 10, 2015</last_update_submitted>
  <last_update_submitted_qc>November 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Nigeria, Enugu Campus</investigator_affiliation>
    <investigator_full_name>Dr C.P. Chijioke</investigator_full_name>
    <investigator_title>Professor C.P. Chijioke</investigator_title>
  </responsible_party>
  <keyword>hypertension</keyword>
  <keyword>dietary intervention</keyword>
  <keyword>personalized nutrition</keyword>
  <keyword>randomized controlled trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

